Q2 2024 Holdings
Filed 2024-08-14 | 60 holdings | $3.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $97.7M | 2,487,762 | 2.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $98.9M | 9,135,893 | 2.8% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $100.3M | 5,750,683 | 2.8% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $115.0M | 3,319,290 | 3.2% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $121.3M | 10,400,158 | 3.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $149.4M | 4,370,024 | 4.2% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $151.9M | 3,186,376 | 4.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $154.1M | 5,161,801 | 4.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $232.1M | 5,981,212 | 6.5% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $956.4M | 21,751,284 | 26.8% |